Výsledky vyhledávání - "Barbara Gastl"

Akademický článek

Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of Pelmeg®, a pegfilgrastim biosimilar in healthy subjects

Autor: Karsten Roth, Dirk Lehnick, Hendrik Wessels, Josef Höfler, Barbara Gastl, Ruediger Jankowsky

Publikováno v: Pharmacology Research & Perspectives, Vol 7, Iss 5, Pp n/a-n/a (2019)

Abstract A pharmacokinetics (PK)/pharmacodynamics (PD) study (EudraCT number 2015‐002966‐21) was conducted to investigate the biosimilarity of Pelmeg® (pegfilgrastim), a biosimilar to EU‐authorized Neulasta®, which is used in the clinic for p

Externí odkaz: https://doaj.org/article/4407a7e68cc545438ca653053638c784

Zobrazit plný text záznamu

Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of Pelmeg, a pegfilgrastim biosimilar in healthy subjects

Autor: Hendrik Wessels, Josef Höfler, Dirk Lehnick, Barbara Gastl, Ruediger Jankowsky, Karsten Roth

Publikováno v: Pharmacology Research & Perspectives, Vol 7, Iss 5, Pp n/a-n/a (2019)

A pharmacokinetics (PK)/pharmacodynamics (PD) study (EudraCT number 2015‐002966‐21) was conducted to investigate the biosimilarity of Pelmeg® (pegfilgrastim), a biosimilar to EU‐authorized Neulasta®, which is used in the clinic for prevention

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41676c94b876e7608d52bdd8cb630683

Zobrazit plný text záznamu

Demonstration of pharmacokinetic and pharmacodynamic equivalence in healthy volunteers for B12019, a proposed pegfilgrastim biosimilar

Autor: K. Jacob, Ruediger Jankowsky, Karsten Roth, Dirk Lehnick, Barbara Gastl

Publikováno v: European Journal of Cancer. 72:S37

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1aec77c74b7f4a4611a8f42f5202518b
https://doi.org/10.1016/s0959-8049(17)30204-6

Zobrazit plný text záznamu

Demonstration of Pharmacokinetic and Pharmacodynamic Equivalence in Healthy Volunteers for B12019, a New Proposed Pegfilgrastim Biosimilar

Autor: Dirk Lehnick, Ruediger Jankowsky, Karsten Roth, Karin Jacob, Barbara Gastl

Publikováno v: Blood. 128:5079-5079

B12019 is being developed as a biosimilar to Neulasta® (INN pegfilgrastim), a long-acting, pegylated form of recombinant human granulocyte-colony stimulating factor (r-metHuG-CSF, INN filgrastim) for the prevention of chemotherapy-induced neutropeni

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cdcedb04743fc07f21433d4e7c2ee35c
https://doi.org/10.1182/blood.v128.22.5079.5079

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání